|
|
Suppliers for
Huperzine A
|
Properties | CAS |
102518-79-6 | Formula |
C15H18N2O |
|
|
13 Registered suppliers
Description : (-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G4 AChE over G1 AChE. Also acts as an NMDA receptor antagonist. Phase 4. - Molecular Weight :242.32
- Purity :> 98%
Molecular Formula : C15H18N2O Canonical SMILES : CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 InChI : InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3-/t10-,15+/m0/s1 InChIKey : ZRJBHWIHUMBLCN-SEQYCRGISA-N Appearance : Powder Application : Ingredient of health care products.
More details are to be found here
Description : (-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G4 AChE over G1 AChE. Also acts as an NMDA receptor antagonist. Phase 4. - Molecular Weight :242.32
- Purity :> 98%
Molecular Formula : C15H18N2O Canonical SMILES : CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 InChI : InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3-/t10-,15+/m0/s1 InChIKey : ZRJBHWIHUMBLCN-SEQYCRGISA-N Appearance : Powder Application : Ingredient of health care products.
More details are to be found here
Description : (-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G4 AChE over G1 AChE. Also acts as an NMDA receptor antagonist. Phase 4. - Molecular Weight :242.32
- Purity :> 98%
Molecular Formula : C15H18N2O Canonical SMILES : CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 InChI : InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3-/t10-,15+/m0/s1 InChIKey : ZRJBHWIHUMBLCN-SEQYCRGISA-N Appearance : Powder Application : Ingredient of health care products.
More details are to be found here
Description : (-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G4 AChE over G1 AChE. Also acts as an NMDA receptor antagonist. Phase 4. - Molecular Weight :242.32
- Purity :> 98%
Molecular Formula : C15H18N2O Canonical SMILES : CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 InChI : InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3-/t10-,15+/m0/s1 InChIKey : ZRJBHWIHUMBLCN-SEQYCRGISA-N Appearance : Powder Application : Ingredient of health care products.
More details are to be found here
Description : (-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G4 AChE over G1 AChE. Also acts as an NMDA receptor antagonist. Phase 4. - Molecular Weight :242.32
- Purity :> 98%
Molecular Formula : C15H18N2O Canonical SMILES : CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 InChI : InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3-/t10-,15+/m0/s1 InChIKey : ZRJBHWIHUMBLCN-SEQYCRGISA-N Appearance : Powder Application : Ingredient of health care products.
More details are to be found here
Description : (-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G4 AChE over G1 AChE. Also acts as an NMDA receptor antagonist. Phase 4. - Molecular Weight :242.32
- Purity :> 98%
Molecular Formula : C15H18N2O Canonical SMILES : CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 InChI : InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3-/t10-,15+/m0/s1 InChIKey : ZRJBHWIHUMBLCN-SEQYCRGISA-N Appearance : Powder Application : Ingredient of health care products.
More details are to be found here
|
Properties:
... more properties and specification on Huperzine A
|
|
Privileged suppliers
Last update 2024-04-29
|